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Anti-SS-A/Ro antibodies have been statistically asso-
ciated with congenital heart block and cutaneous lupus 
in the neonatal lupus syndrome, and with photosensitive 
cutaneous lupus in subacute cutaneous lupus erythema-
tosus, but it had not been demonstrated that SS-A/Ro 
antigen is present in fetal tissues or at any age in human 
skin. We e xamined normal fetal tissues, normal neonatal 
and adult skin, and keratinocytes from purified serum-
free cultures by immunofluorescence (IF) and by im-
munodiffusion or counterimmunoelectrophoresis (CIE) 
to determine the presence of SS-A/Ro antigen. We found 
SS-A/Ro antigen to be present in fetal hearts and in 
other internal organs. SS-A/Ro antigen could be dem-
onstrated in biopsies of neonatal and adult skin by IF 
and was confirmed to be in keratinocytes by CIE. SS-A/ 
Ro antigen may be found on the surface of keratinocytes 
in culture and therefore may be present at a relevant 
site for antibody binding. 
We have shown that SS-A/Ro antigen is a normal 
component of tissues that may be affected in neonatal 
lupus (fetal myocardium, neonatal epidermis) and in 
subacute cutaneous lupus erythematosus (adult epider-
mis). 
Autoantibodies to t he SS-A/ Ro antigen have a strong statis-
tical association with neonatal lupus syndrome and with sub-
acute cutaneous lupus erythematosus [1- 4). In the neonatal 
lupus syndrome, affected infants have congenita l heart block, 
cutaneous lupus, or both [2]. Mothers of these infants have 
circulating anti-SS-A/Ro antibodies that are passed through 
the placenta to the child and may be related to the production 
of disease. Supporting the role of anti -SS-A/ Ro antibodies in 
the production of disease is the observation that the duration 
of cutaneous disease in the infant roughly para llels t he duration 
of the maternally derived anti-SS-A/Ro antibodies in the in-
fant's serum. 
Adults with subacute cutaneous lupus erythematosus have 
disease t hat is predominantly cutaneous and shares several 
cl inical features with the cutaneous disease in neonatal lupus 
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syndrome (4) . The majority of subacute cutaneous lupus pa-
tients have detectable anti -SS-A/Ro ant ibodies in their sera. 
In both of these diseases, therefore, there is circumstantial 
evidence that ant i-SS-A/Ro ant ibodies are involved in the 
pathogenesis of the disease. One difficulty with implicating t he 
antibody in the disease process is that SS-A/Ro antigen had 
not been demonstrated in neonatal or adult skin or in fetal 
myocardium, major sites of tissue injury in these diseases. We 
examined fe tal tissues and neonatal and adult skin to determine 
whether SS-A/Ro antigen is normally present in t hese loca-
tions. 
MATERIALS AND METHODS 
Tissues 
Normal fetal tissues were studied at 16- 18 weeks gestational age, 
the earliest age at which congenital heart block has been detected. 
Fetal hearts, livers, spleens, kidneys, and skin were obtained afte r 
written consent from mothers undergoing elective saline- induced abor· 
t ions. All tissues were received within an appropriate period for t he 
detection of 88-A/Ro a nt igen [5], no more than 4 h postdelivery, and 
were snap-frozen in liquid nit rogen. Neonata l skin was obtained from 
circumcisions, and adult skin was obtained from 4-m m punch biopsies 
of normal skin , in each case after written permission from t he respon-
sible party. Neonatal foreskins were collected in a physiologic salt 
solut ion, then frozen at -70"C. Adult skin biopsies were immediately 
frozen in liquid nitrogen . 
Tissues used as controls were mouse kidney, a negative control; and 
HEp-2, derived from a human epi t helia l cell line, a posit ive cont rol. 
Keratin.ocyte Cultures 
l<eratinocytes for ce ll cultures were derived from neonata l skin 
obtained from circumcisions. The subcutaneous fat was trimmed from 
the fo reskins, then the skin was cut into 2 X 2 mm pieces. T he sections 
of skin were incubated in collagenase (2.5 mg/ml) at 3TC for 90 min . 
Epiderma l sheets were peeled off t he dermis, and eit her placed in to 
phosphate-buffered saline (PBS), pH 7.2, for immediate use in immu-
nodiffusion (ID) and counte rimmunoelectrophoresis (CIE) , or cul tured 
in serum-free MCDB solution (U nivers ity of Colorado Department of 
Molecular, Cellula r, a nd Developmental Biology, Bou lde r, Colorado) 
for 5- 7 days in a 3TC incubator with 5% C02. These keratin ocyte 
cultures were first-passage nonstrati(ying keratinocytes, grown in Lab-
Tek chamber slides (M iles Laboratories, Naperville, Illinois). T he 
cultures consisted of 100% keratinocytes, as p reviously determined 
with a ntikeratin antibodies. 
Sera 
To determine the presence of 88-A/Ro a nt igen in these t issues, 3 
di ffe rent ant i-SS -A/ Ro sera were used in t he immunofluorescence (IF) 
studies. These sera were considered monospeciflc by t he fo llowing 
criteria : (1) t he demonstration of a negative fluorescent antinuclear 
ant ibody (ANA) test on mouse kidney but a posit ive ANA on t he 
human cell line, HEp-2; (2) t he presence of a single precipitin li ne 
against an extract of Wil2, a lymphoblastoid cell line known to contain 
SS-A/Ro antigen: (3) a line of identity with a nt i-88-A/ Ro reference 
sera; and (4) t he absence of any other precipitin in t he reactions to 
eit her Wil2 extract or rabbit t hymus extract (RTE), whether to iden-
tifiable antigens such as Sm or RNP or to unidentified ant igens. T hese 
3 anti-88-A/ Ro sera were from patients with the following clinical 
findin gs: (a) a 32-year-old female with subacute cutaneous lupus, (b) a 
29-year-old female wit h subacute cutaneous lupus who had 2 children 
with cutaneous neonata l lupus, and (c) a 63-year -old male with occa-
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sional mild ac hes and no other symptoms. Se rum (a) had a titer of 1:10 
on HEp-2 cells, while sera (b) and (c) had a titer of 1:100 on HEp-2 
ce lls. The specificity of se rum (c) had been further demonstrated by 
the isolation of monospecific anti -SS-A/ Ro antibodies from immuno-
precipitates of SS-A/Ro antigen and antibodies [5]. These isolated SS-
A/ Ro antibodi es reacted with SS-A/ Ro antigen and formed a line of 
identity wi t h ant i-SS-A/ Ro reference se rum. 
To determine the presence of SS-A/ Ro antigen in tissue extracts, 2 
reference anti-SS-A/ Ro sera were used in the immunoprec ipitation 
studies. These reference sera, obta ined from the rheumatology l<tbora-
to ries at the University of Colorado, were monospecific according to 
the above cri te ria. One of these was se rum (c) used in the IF studies. 
Normal human se ra for use as negative cont rols were obtained from 
healthy volunteers. Examination of these sera for fluoresce nt ANA was 
negative on both mouse kidney and on HEp-2 cell substrate. Positive 
co ntrol sera consisted of se ra co nta ining antibodies to double-s tranded 
DNA which had strongly positive homogeneous nuclear IF on both 
mouse kidney and HEp-2 cell substrates. 
Immunofluorescence 
Frozen sections 4 11m t hick were prepared from the fetal , neonatal, 
and adult tissues. The tissue sections were fix ed in 100% acetone for 1 
min , then incubated with either anti-SS-A/Ro serum, with normal 
human serum, or wit h positive cont rol serum, each diluted 1:10 and 
J:J 00, at.. room temperature for :30 min. The slides were washed in PBS, 
then incubated with 20% normal rabbit serum in PBS at room tem-
perature for 10 min to diminish nonspecific binding of the rabbit 
flu orescein conjugate to the tissues. The slides were then incubated 
wi th fluorescein -conjugated rabbit antihuman lgG (Cal Biochem-Behr-
ing, San Diego, Californ ia) at room temperature for 30 min. The washed 
slides were dipped for 30 s in a propidium iodide solution to coun -
te rstain the nuclei. A coverslip moun ting medium consisting of a 9:1 
glycerol:PBS solution, pH 8.5, containing 0.1 % paraphenylenediamine 
[6], was used. The slides were examined on a Zeiss flu orescent micro-
scope equipped wi th an epi -illumination system, an HB0-100 mercury 
light source, and a filter-refl ector sytem for flu orescein. 
For keratinocyt.e cultures, the procedure was the same except for the 
fixation step. ,For staining of antigens within the cells, the chambers of 
the culture slides were removed and t.he cells on the slides were fi xed 
in acetone to render the ce ll membranes permeable and to adhere the 
ce ll s to the slides. The IF procedure was then done as desc ribed above_ 
When cell surface antigens we re examined, the cells were first incu-
bated at 37•c for 30 min wi th the test sera before fixation in acetone, 
then incubation with the fluorescein conjugate. 
Immunodiffusion. 
Tissue extracts and keratinocyte extracts were prepared for 10 by 
mincing the tissue in to PBS (0.01 M phosphate, 0.15 M NaCl, pH 7.2, 
1 ml PBS/90 mg t issue), mec hanica lly pulveri zing the tissue, and 
stirring at 4 ·c overni ght. The tissue was then furth er disrupted by 
ultrasonication with 15-s bursts 8 times. The preparation was centri-
fuged at 10,000 rpm for 1 h. The prote in content of these extracts was 
15- 20 mg/ml. The supernatant was placed in the central well of an 
Ouchterlony pl ate (0.6% agarose and O.J % sodium azide). In the other 
wells were anli -SS-A/Ro reference se ra or an extract of the lympho-
blastoid cell line, Wil2 , a kn own source of SS-A/ Ro antigen. The plates 
were exa mined for precipitin lines at 24 - 48 h. 
Cou.n terimm.unoelectrophoresLs 
Because of the small vo lume of some extracts, a standard CIE 
technique 15] was used in lieu of 10 in some cases t.o test for the 
presence of SS-A/ Ro antigen. Tissue extrac ts and kerat.inocyte extracts 
were prepared as describe-d above. 
RESULTS 
The presence of SS-A/ Ro antigen was demonstrated in a ll 
fetal myoca rdi a by IF , by ID, a nd by ClE (Table I) . By IF , 
particulate nuclea r and cytoplasmic staining was observed in 
virtually a ll cells in a ll sections of heart examined. The majority 
of IF sta ining was concentrated in t he nuclei (Fig la) . Sections 
were taken from at least 5 a reas of eac h heart examined_ Atrial 
wa ll , ventricul a r wa ll, a nd septum, including the conduction 
system, were studied in eac h case- No IF staining was seen with 
the no rmal human serum control (Fig lb). By ID , a single 
prec ipitin line of identity was demonstrated when fetal heart 
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TABLE I. Demonstration of SS-A/ Ro antigen in human fetal tissues 
and in neonatal and adult epidermis 
Feta l myocardium 
Fetal kidney 
Fetal liver 
Fetal spleen 
Fetal epidermis 
Neonatal epidermis 
Adult epidermis 
Immunonuorescence 
(#spec imens pos itive/ 
#specimens 
examined) 
8/8 
5/5 
5/5 
5/5 
0/5 
5/7 
8/JO 
ID or CIE 
+ 
+ 
+ 
+ 
NO 
+ 
NO 
Key: ID = immunodiffusion; CIE = counterimmunoelectrophoresis; 
NO = not. done. 
extract (FHE) was reacted against 2 anti-SS-A/ Ro reference 
sera (Fig 2). When an extract of Wil2 cells, a known source of 
SS-A/Ro antigen, was placed in a well adjacent to the FHE 
and reacted against anti-SS-A/ Ro sera, lines of immunologic 
identity were observed_ 
SS-A/Ro antigen was also present in other fetal tissue sec-
tions and extracts as determined by IF, ID, and CIE (Table I). 
The staining in all these organs was present in all sections 
studied and co nsisted of particulate nuclear and cytoplasmic 
stain ing. 
SS-A/Ro antigen was present in neonatal skin by all 3 
methods . By IF, particulate nuclea r staining was present in 
keratinocytes in 5 of 7 biopsies examined (Fig 3a). No IF 
staining was seen in any of the specimens with the negative 
control sera (Fig 3b ). ID and CIE demonstrated the presence 
of the antigen in neonatal skin extract, consisting of neonatal 
ep idermis and dermis. 
In the skin , t he major cell exhibiting histologic evidence of 
injury in neonatal and subacute cutaneous lupus is the basal 
keratinocyte. To confirm that SS-A/Ro antigen is in the kera-
t inocyte, we examined cultured keratinocytes by IF and extracts 
of cu ltured keratinocytes and epidermal sheets by CIE. By IF, 
SS-A/Ro antigen cou ld be demonstrated in t he nucleus and 
cytoplasm of cultured nonstratified keratinocytes. As has been 
recently described, SS-A/Ro antigen also appeared to be pres-
ent in some cases on the cell surface of cult ured keratinocytes 
(Fig 4a, b) [7) . By CIE, SS-A/Ro antigen could be demonstrated 
both in pure cultures of nonstratified keratinocytes and in 
freshly separated epide rmal sheets. 
In feta l skin of 16- 18 weeks gestational age, SS-A/ Ro antigen 
was not found by IF in the fetal epithe lium. The a ntigen was 
present by IF, however, in some areas of fetal dermis. SS-A/ 
Ro antigen was present by ID and ClE in an extract of whole 
fetal skin consisting of both dermis and epithelium _ 
By IF, SS-A/Ro antigen was present in adult keratinocytes 
(Fig 5) and in adult dermis. The staining seen was of a partic-
ulate pattern identical to that in neonatal skin and was seen in 
8 of 10 biopsies examined. The finding of SS-A/Ro antigen in 
adu lt skin was not clearly related to the age or sex of t he donor 
or to the anatomic site of the biopsy, including whether t he 
biopsy was from sun-exposed or sun-protected skin (data not 
shown). ID and CIE were not done because of an insufficient 
amount of tissue in the adu lt skin biopsies. 
DISCUSSION 
Neonatal lupus syndrome is characterized by either congen-
ital heart block or cutaneous lupus, or both , in t he affected 
infant. Mothe rs of these infants may have systemic lupus 
erythematosus, sicca syndrome, or subacute cutaneous lupus, 
but some have mild arthralgias or sun sensitivity on ly, and 
about 50% of mothers are asymptomatic [3,8]. The unifying 
feature of these mothers appears to be the presence of antibod-
ies to the SS-A/Ro antigen . The anti-SS-A/Ro antibodies of 
t he mothers a re of the lgG class, cross the placenta, and can 
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F IG 2. Feta l hea rt. extract (FH E, cente r well ) exa mined by immu· 
nodiffusion for t he prese nce of S8-A/ Ro a nt igen. Two a nti -88-A/ Ro 
contain ing sera (periphera l we lls, SS-A I a nd S '-A2), demonstrate a 
s ingle precipi t in line of identi ty confirming the presence of 88-A/ Ro 
antigen in the extract of fetal hea rt. 
Ftc 3. a, Neo natal skin exa mined by immunofluorescence for SS· 
A/ Ro a ntigen, x 630. There is pa rt icu late staining of ke ratinocyte 
nuclei indicating the precence of 88-A/ Ro antigen. b, Negative cont rol, 
neo n atal skin exa mined hy immunoflu oresce nce with norma l human 
serum, X 630. There is 11 0 immunofluorescent sta ining of keratinocytes. 
Nuclei have been counterstained wit h propidium iodide. 
be found in the sera of the infants for the first few mon t hs of 
life. The ant i-88-A/Ro ant ibodies di sappear from the infants' 
se ra at about the t ime the cutaneous lesions resolve [2]. Of the 
53 neonatal lupus cases reported where anti -88-A/ Ro antibod-
ies we re examined, 50 had ant i-88-A/Ro ant ibodies [1- 4, 
9- 15], and in many patients these were t he on ly autoant ibodies 
detected. · 
Anti-88-A/ Ro antibodies a re found in 80% of patients wi th 
subacute cuta neous lupus [16]. The cutaneous disease, as in 
neon ata l lupus, is characte rized by nonscarring extensive pho-
todistributed erythematous plaques. 8ont heimer et al noted the 
F IG l. a, Fetal myocardium exa m· 
ined by indirect immunofluorescence fo r 
the presence of SS-A/ Ro antigen, X 630 
in original magnificat.ion. There is par· 
ticu late staining of nuclei (arrows), in-
dicating t he presence of SS-A/ Ro a nt i-
gen. b, Negative control, fetal myocar-
dium examined by immunofluorescence 
wit h normal human se rum, X 630. There 
is no immunofluoresce nt staining. 
FIG 4. a, Keratinocytes in culture, examined by immunofluores-
cence for t he presence of SS-A/Ro antigen on the cell surface, X 630. 
There is pa rticulate staining of t he cells, indicating binding of antibody 
to the cell surface. (The nucleolar accentuation in the nuclei is a resu lt. 
of t he propidium iodide counterstain and is also seen in t he negative 
cont rol, Fig 4b.) b, Negative cont rol, keratinocytes in culture exam ined 
for ce ll surface binding of antibodies in normal huma n serum , X 630. 
T here is no evidence of antibody binding. Nuclei have been cou nter-
stained with propidium iodide. 
FIG 5. Adult human skin examined by immunofluorescence for 88-
A/ Ro a ntigen , X 630. Epide rmis (E), dermis (D), a nd particulate 
immunofluorescent staining of kerat.inocytes (a rrow) are not.ed on the 
photomicrograph. The particulate staining of keratinocytes indicaies 
t he prese nce of 88-A/ Ro a nt igen. 
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strong statistica l association with anti-SS-A/Ro antibodies but 
were reluctant to ascribe cause-and-effect to t he antibodies 
si nce the antigen had not been found in skin [4]. 
SS-A/Ro antigen has been characterized as a protein of Mr 
60,000 attached to an RNA of Mr 30,000- 40,000, making the 
Mr of the complex approx imately 100,000 [17,18]. It is a non-
histone highly soluble antigen that is found in t he nucleus and 
frequently a lso in t he cytoplasm of various mammalian cells. 
It is not detected by IF in the nucleus or cytoplasm of mouse 
or rat kidney or liver, substrates often used in routine ANA 
examination [19]. SS-A/Ro antigen has been demonstrated by 
IF on adult human kidney [5], liver [5], and peripheral blood 
mononuclear cells (20], and on cultured HEp-2 cells [5], lym-
phoblastoid Wil 2 cells [5], and cultured lung fibroblasts.[5]. 
The presence of SS-A/Ro antige n had not been reported in 
fetal tissues or in biopsies of neonatal or adult skin , t hus SS-
A/Ro antigen had not been demonstrated to be present in 
tissues injured in neonatal lupus or subacute cutaneous lupus. 
We have found by IF, ID, and CIE that SS-A/Ro ant igen is 
present in fetal myocardium at 16- 18 weeks gestational age , 
the earliest gestational age at which heart block has been 
detected in neonatal lupus, and that SS-A/Ro antigen is present 
in neonatal and adu lt skin. In skin it is found not only in the 
connective t issue of the dermis but, more pertinently, in kera-
tinocytes, where there is histologic evidence of injury in cuta-
neous neonatal lupus a nd subacute cutaneous lupus. When 
examining for SS-A/Ro antigen, it is important to note that 
the antigen may be soluble in salt and in a lcohol solutions, so 
t hat handling of the specimens is cri t ical (5]. These technical 
problems make the interpretation of negative results difficult. 
While it is interesting that SS-A/Ro antigen was not detected 
in fetal epithelium, the fetal epithelia were handled consider-
ably differently from neonatal and adu lt skin, and we feel that 
it is premature to conclude that SS-A/Ro antigen is not present 
in feta l epithelium. 
It is significant that SS-A/Ro antigen appears to be present 
in cul ture on the keratinocyte cell surface, a location where it 
may be accessible to antibody. LeFeber et a l have reported that 
exposure to UV radiation augments binding of anti-SS-A/Ro 
antibody to keratinocyte cell surfaces, and have proposed t hat 
that may be related to t he photosensitivity seen in neonatal 
lupus and subacute cutaneous lupus [7] . 
We have further evidence that SS-A/Ro antigen may be on 
keratinocyte cell surfaces. In an animal model, the nude mouse 
with grafted human skin, i.v. injected anti-SS-A/Ro antibody 
binds in vivo to human keratinocytes, and t he antibody binding 
is increased after exposure of the skin graft to UV rad iation 
[21] . In this model, all 40 skin grafts from 6 different normal 
adult donors had SS-A/Ro antigen present in keratinocytes by 
IF, and a ll 26 animals injected with a nt i-SS-A/Ro sera had 
antibody binding to basal keratinocytes. The antibodies bound 
in vivo were often observed to be outlining histologically normal 
keratinocytes, a pattern suggestive of ce ll surface bindi~g. 
Though the SS-A/Ro antigen would appear to be v1rtually 
ubiquitous in human tissue, neonatal lupus and subacute cu-
taneous lupus usually involve a limited number of organs. The 
reason for this remains to be established. Except for the human 
keratinocyte cultures and the nude mouse studies, we did not 
use techn iques that would clearly determine t he presence of 
SS-A/Ro antigen on cell surfaces, so it is not known whether 
expression of t he antigen on cell surfaces, where it may be more 
accessible to antibody binding, is limited to a few locations or 
is a characteristic of a ll tissues. 
We have demonstrated t hat SS-A/Ro antigen is present in a 
number of fetal tissues and in neonatal and adult skin, and in 
particular have shown that it is present in locations where 
tissue injury occurs in the anti-88-A/Ro-associated diseases, 
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neonatal lupus and subacute cutaneous lupus. Based on these 
results, it is tenable to postulate that anti-88-A/Ro antibodies 
may bind to SS-A/Ro antigen in situ and may be important in 
the production of disease. 
Addendum 
Since t he acceptance of this paper, we have demonstrated 
the presence of SS-A/Ro antigen in adult epidermis by coun-
terimmunoelectrophoresis. The tissue used for this study was 
normal skin discarded after abdominoplasty. The epidermis 
was separated from the dermis with collagenase, and prepared 
and examined by the methods described in this manuscript. 
The authors wish to thank Dr. John Ryder for his assistance in 
obtaining tissues. 
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